Pasar al contenido principal

MARCO METODOLOGICO PARA LA MONITORIZACION ONLINE DE LA DOSIS-RESPUESTA EN LA APERTURA DE LA BARRERA HEMATOENCEFALICA MEDIANTE ULTRASONIDO FOCAL

PID2021-127800OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION DE INVESTIGACION HM HOSPITALES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The road ahead to successful BBB opening and drug-delivery with focused ultrasound

  • López-Aguirre, Miguel
  • Castillo-Ortiz, Marta
  • Viña-González, Ariel
  • Blesa, Javier
  • Pineda-Pardo, José A.
This review delves into the innovative technology of Blood-Brain Barrier (BBB) opening with low-intensity focused ultrasound in combination with microbubbles (LIFU-MB), a promising therapeutic modality aimed at enhancing drug delivery to the central nervous system (CNS). The BBB's selective permeability, while crucial for neuroprotection, significantly hampers the efficacy of pharmacological treatments for CNS disorders. LIFU-MB emerges as a non-invasive and localized method to transiently increase BBB permeability, facilitating the delivery of therapeutic molecules. Here, we review the procedural stages of LIFU-MB interventions, including planning and preparation, sonication, evaluation, and delivery, highlighting the technological diversity and methodological challenges encountered in current clinical applications. With an emphasis on safety and efficacy, we discuss the crucial aspects of ultrasound delivery, microbubble administration, acoustic feedback monitoring and assessment of BBB permeability. Finally, we explore the critical choices for effective BBB opening with LIFU-MB, focusing on selecting therapeutic agents, optimizing delivery methods, and timing for delivery. Overcoming existing barriers to integrate this technology into clinical practice could potentially revolutionize CNS drug delivery and treatment paradigms in the near future., This review was supported by the Fundación de Investigación HM Hospitales (Madrid); Ministerio de Ciencia e Innovación y Universidades, Spanish Government (Grant number PID2021-127800OA-I00); Instituto de Salud Carlos III Miguel Servet (MS19/00200) and FIS (PI23/00672)., Peer reviewed